Aimmune Therapeutics logo

Aimmune Therapeutics Employee Directory

Biotechnology ResearchCalifornia, United States51-200 Employees

Aimmune Therapeutics is a biopharmaceutical company focused on developing and commercializing therapies for potentially life-threatening food allergies. Its Characterized Oral Desensitization ImmunoTherapy (CODIT) approach desensitizes patients with defined, precise amounts of key allergens to reduce reactions from accidental exposure. The company currently has one FDA-approved medicine for peanut allergy and is pursuing additional therapies for other food allergies. Headquartered in Brisbane, California, in the San Francisco Bay Area's biotech hub, Aimmune maintains offices in Durham, North Carolina; the Paddington area of London; Dublin, Ireland; and Munich, Germany, and is part of Nestlé Health Science.

Find Aimmune Therapeutics employees' phone numbers or email addresses

Aimmune Therapeutics Global Highlights

Location
Employees

North America
152

Minus sign iconPlus sign icon
  • United States Of America
    151
  • Canada
    1

Europe
14

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    9
  • Switzerland
    4
  • France
    1

Asia
2

Minus sign iconPlus sign icon
  • Indonesia
    1
  • India
    1

Aimmune Therapeutics's Leadership

  • Chief Financial Officer at Aimmune Therapeutics
    E. B.
    Chief Financial Officer
  • Vice President Investor Relations at Aimmune Therapeutics
    L. H.
    Vice President Investor Relations
  • Vice President Market Access And Pricing at Aimmune Therapeutics
    M. F.
    Vice President Market Access And Pricing
  • Vice President Clinical Development at Aimmune Therapeutics
    S. M.
    Vice President Clinical Development
  • President at Aimmune Therapeutics
    P. O.
    President
  • Head Of Clinical Operations Eu, Senior Director, Aimmune Therapeutics at Aimmune Therapeutics
    M. C.
    Head Of Clinical Operations Eu, Senior Director, Aimmune Therapeutics
  • Head Of Strategy And Business Transformation at Aimmune Therapeutics
    H. L.
    Head Of Strategy And Business Transformation
  • Ea To Chief Medical Officer, Senior Vice President Regulatory Affairs And Svp, Global Head Medical Affairs at Aimmune Therapeutics
    Y. A.
    Ea To Chief Medical Officer, Senior Vice President Regulatory Affairs And Svp, Global Head Medical Affairs

Aimmune Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Customer Success
  • Sales
  • Quality Assurance
  • Operations
  • Accounting
  • Other
  • Consultant
  • Research
  • Engineering
  • Administrative
  • Biotechnology
  • Legal
  • Branding

Contact profiles from Aimmune Therapeutics

Name
Title
Contact
Location
Last Update
  • Director, Medical Writing at Aimmune Therapeutics
    G. R. S.
    Director, Medical Writing
    United Kingdom, England
    Aug 31, 2026
  • Senior Director Of Operations at Aimmune Therapeutics
    J. P.
    Senior Director Of Operations
    Germany, Hesse
    Aug 03, 2026
  • Associate Director Of Global Commercial Supply Chain at Aimmune Therapeutics
    A. K.
    Associate Director Of Global Commercial Supply Chain
    May 21, 2025
  • Controller at Aimmune Therapeutics
    A. M.
    Controller
    Oct 17, 2024
  • Director at Aimmune Therapeutics
    A. P.
    Director
    Jun 25, 2025
  • Executive Director, Leadership And Organizational Development at Aimmune Therapeutics
    B. E.
    Executive Director, Leadership And Organizational Development
    Aug 03, 2025
  • Senior Director Quality Assurance at Aimmune Therapeutics
    H. G. M.
    Senior Director Quality Assurance
    Oct 23, 2024
  • Senior Director, European Strategy & Commercial Operations at Aimmune Therapeutics
    J. B.
    Senior Director, European Strategy & Commercial Operations
    United Kingdom
    Aug 13, 2026
  • Associate Director Of Msls at Aimmune Therapeutics
    J. L.
    Associate Director Of Msls
    Apr 24, 2025
  • Director Business Insights at Aimmune Therapeutics
    K. T.
    Director Business Insights
    Oct 22, 2024

Frequently Asked Questions

What is Aimmune Therapeutics known for?

Minus sign iconPlus sign icon
Aimmune Therapeutics was founded in 2011 and operates in the Biotechnology Research industry. You can contact Aimmune Therapeutics's main corporate office by phone at . Explore Aimmune Therapeutics's company overview page for more information.

What is Aimmune Therapeutics's most common email format?

Minus sign iconPlus sign icon
Aimmune Therapeutics employees' email format typically follows the pattern of FLast@aimmune.com. Trying to find reliable and up-to-date employee contact data? Find more Aimmune Therapeutics email formats with LeadIQ.

How many employees does Aimmune Therapeutics have currently?

Minus sign iconPlus sign icon
Aimmune Therapeutics has approximately 67 employees as of August 2026. These team members are located across 3 continents, including North America, Europe and Asia.

Who are Aimmune Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Aimmune Therapeutics's key employees include:

  • Chief Financial Officer: E. B.
  • Vice President Investor Relations: L. H.
  • Vice President Market Access And Pricing: M. F.
  • Vice President Clinical Development: S. M.
  • President: P. O.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.